Skip to search formSkip to main contentSkip to account menu

EP 217609

Known as: EP-217609, EP217609 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
EP217609 is a parenteral antithrombotic compound combining in one molecule an indirect anti-factor Xa inhibitor, a direct… 
2016
2016
IntroductionEP217609 is a representative of a new class of synthetic parenteral anticoagulants with a dual mechanism of action… 
2016
2016
EP217609 is a representative of a new class of synthetic parenteral anticoagulants with a dual mechanism of action. It combines… 
Review
2015
Review
2015
RésuméObjectifL’héparine et la protamine constituent la stratégie d’anticoagulation de référence en chirurgie cardiaque sous… 
Review
2015
Review
2015
Heparin anticoagulation followed by protamine reversal is commonly used in cardiopulmonary bypass (CPB) cardiac procedures, but… 
2014
2014
Summary EP217609 is a new synthetic parenteral dual-action anticoagulant combining a direct thrombin inhibitor (α-NAPAP analog… 
Review
2009
Review
2009
Summary The elucidation of the structure of the antithrombin binding sequence in heparin has given a large impulse to the…